Stocks and Investing Stocks and Investing
Tue, July 26, 2022

David Nierengarten Initiated (VOR) at Buy and Held Target at $18 on, Jul 26th, 2022


Published on 2024-10-27 22:11:44 - WOPRAI, David Nierengarten
  Print publication without navigation


David Nierengarten of Wedbush, Initiated "Vor Biopharma Inc." (VOR) at Buy and Held Target at $18 on, Jul 26th, 2022.

David has made no other calls on VOR in the last 4 months.



There are 2 other peers that have a rating on VOR. Out of the 2 peers that are also analyzing VOR, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Andrea Tan of "Goldman Sachs" Maintained at Hold with Decreased Target to $4 on, Tuesday, May 24th, 2022


This is the rating of the analyst that currently disagrees with David


  • Silvan Tuerkcan of "JMP Securities" Maintained at Buy with Decreased Target to $15 on, Friday, May 13th, 2022
Contributing Sources